Video
Author(s):
At The European Society of Cardiology Congress 2016 (ESC), Ibrahim Danad, MD, VU University Medical Center, Amsterdam, Netherlands, explained the results from his team's PACIFIC trial, which assessed two non-invasive coronary artery imaging tools: positon emission tomography (PET) and single photon emission computed tomography (SPECT).
At The European Society of Cardiology Congress 2016 (ESC), Ibrahim Danad, MD, VU University Medical Center, Amsterdam, Netherlands, explained the results from his team's PACIFIC trial, which assessed two non-invasive coronary artery imaging tools: positron emission tomography (PET) and single photon emission computed tomography (SPECT). He also shared that the difference in key imaging tools used in the US vs. Europe was due to FDA and EU approvals. Danad did say that findings showed PET had more diagnostic accuracy; however, he emphasized that European and US guidelines are not yet advocating one over the other.